IDWEEK14
Latest Post

IDWeek: Children may be spared from Ebola infection but not its impact

While children are “relatively spared” from becoming infected with Ebola due to limited contact with Ebola patients compared to adults, children in Guinea, Sierra Leone, and Liberia have to deal with a myriad of other problems that leave them vulnerable to other diseases and poor health, said Barbara Mahon of the Centers for Disease Control […]

More »

Recent Posts

IDWEEK14

IDWeek: Some progress in TB drug and diagnostic development, but not enough

The emerging crisis of multidrug-resistant tuberculosis is a “personal and health system catastrophe” that’s occurring half a million times a year in the form of new cases, Eric Nuermberger said at an IDWeek session on HIV-related opportunistic diseases. Not only is it an intensively difficult disease to treat, requiring up to two years of therapy […]

More »
IDWEEK14

IDWeek: Look at behavior economics to improve ART adherence

Making HIV medications free or low cost is very important for removing barriers to HIV care access, but it’s not enough to ensure adherence, Kevin Volpp said at IDWeek. HIV/AIDS programs must take behavioral economics into account when designing programs to promote adherence and ensure people living with HIV remain in the cascade of care. […]

More »
DrFischer

Ebola: “This is what it was like to respond to HIV,” doctor home from Guinea says

At the end of last May, Dr. William Fischer was immersed in his work as a physician, researcher, and instructor at the University of North Carolina in Chapel Hill when he answered a call from the World Health Organization. He had been recognized the year before with the Infectious Diseases Society of America’s Young Investigator […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

IDWeek: Look at behavior economics to improve ART adherence

Making HIV medications free or low cost is very important for removing barriers to HIV care access, but it’s not enough to ensure adherence, Kevin Volpp […]

Tuberculosis

IDWeek: Some progress in TB drug and diagnostic development, but not enough

The emerging crisis of multidrug-resistant tuberculosis is a “personal and health system catastrophe” that’s occurring half a million times a year in the form of new […]

Research & Development

Ebola vaccine candidate safety study to launch next week at NIH

The U.S. National Institute of Allergy and Infectious Diseases will begin human testing of a vaccine candidate to prevent Ebola virus disease at the National Institutes […]

Policy

Ebola: “This is what it was like to respond to HIV,” doctor home from Guinea says

At the end of last May, Dr. William Fischer was immersed in his work as a physician, researcher, and instructor at the University of North Carolina […]